Condition: Coronary Artery Disease · Sponsor: Fundación EPIC
To evaluate the efficacy of the two DES (Drug Eluting Stent) used in terms of device-related adverse events at 12 months after PCI (Percutaneous Coronary Intervention). To compare the clinical safety and efficacy by comparing net clinical events (defined as the combination of ischemic and hemorrhagic events) of the two DES used at 12 months after PCI.
This description comes directly from the study's public registry record.
Armando Pérez de Prado, MD, PhD · 0034987876135 · admin@fundacionepic.org
FUNDACION EPIC · 0034987876135 · iepic@fundacionepic.org
Always discuss trial participation with your own doctor first.
| Hospital Universitario San Juan Alicante | Alicante, Spain | Recruiting |
| Hospital Universitari Germans Trias I Pujol | Badalona, Spain | Recruiting |
| Hospital Universitario de Cruces | Barakaldo, Spain | Recruiting |
| Hospital Universitari Vall d'Hebron | Barcelona, Spain | Recruiting |
| Hospital General Universitario de Castellon | Castelló, Spain | Recruiting |
| Hospital Universitario de Donostia | Donostia / San Sebastian, Spain | Recruiting |
| Hospital Universitario Virgen de La Arrixaca | El Palmar, Spain | Recruiting |
| Hospital Universitario La Paz | Fuencarral-El Pardo, Spain | Recruiting |
| Hospital Universitario Juan Ramón Jiménez | Huelva, Spain | Recruiting |
| Hospital Universitario de Leon | León, Spain | Recruiting |
| Hospital Universitari Arnau de Vilanova | Lleida, Spain | Recruiting |
| Hospital Universitario Lucus Agustí | Lugo, Spain | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07190690